The collaboration between Ferring Pharmaceuticals and Antares Vision Group continues: for the leader in reproductive medicine a new testing and validation software and a better supply of spare parts which increases the efficiency of the production process.

From traceability regulations compliance to a customized service

Antares Vision Group is technology partner in digitalization and innovation for companies, institutions and governments, guaranteeing safety and quality, sustainability and efficiency of products and supply chains to build trust.
 It provides a unique and integrated ecosystem of technologies – including software and hardware – to guarantee product quality (inspection systems and equipment) and end-to-end traceability (from raw materials to production, from distribution to the consumer), through connected data management, applying artificial intelligence and blockchain .
AV Group is active in the Life Science  (pharmaceuticals, medical devices, and hospitals), Beverage, Food, Cosmetics, Chemicals and Packaging  and potentially in many other industries. The world leader in track and trace solutions for pharmaceutical products, it provides major global pharma manufacturers (more than 50% of the Top 20 multinationals) and several government authorities with solutions to monitor their supply chains and validate product authenticity.
Listed since April 2019 on the Italian Stock Exchange in the Alternative Investment Market (AIM) segment and from 14 May 2021 in the STAR segment of the Mercato Telematico Azionario (MTA) (electronic equity market), AV Group recorded a turnover of Euro 179 million in 2021, operates in more than 60 countries, employs more than 1,100 people, and has a consolidated network of more than 40 international partners. For more information, visit antaresvision.com and antaresvisiongroup.com.

News

Technology

Business News

Antares Vision Group is technology partner in digitalization and innovation for companies, institutions and governments, guaranteeing safety and quality, sustainability and efficiency of products and supply chains to build trust. It provides a unique and integrated ecosystem of technologies – including software and hardware – to guarantee product quality (inspection systems and equipment) and end-to-end traceability (from raw materials to production, from distribution to the consumer), through connected data management, applying artificial intelligence and blockchain . AV Group is active in the Life Science (pharmaceuticals, medical devices, and hospitals), Beverage, Food, Cosmetics, Chemicals and Packaging and potentially in many other industries. The world leader in track and trace solutions for pharmaceutical products, it provides major global pharma manufacturers (more than 50% of the Top 20 multinationals) and several government authorities with solutions to monitor their supply chains and validate product authenticity. Listed since April 2019 on the Italian Stock Exchange in the Alternative Investment Market (AIM) segment and from 14 May 2021 in the STAR segment of the Mercato Telematico Azionario (MTA) (electronic equity market), AV Group recorded a turnover of Euro 179 million in 2021, operates in more than 60 countries, employs more than 1,100 people, and has a consolidated network of more than 40 international partners. For more information, visit antaresvision.com and antaresvisiongroup.com.

Share From traceability regulations compliance to a customized service

Sign up to save your podcasts

From traceability regulations compliance to a customized service

From traceability regulations compliance to a customized service